Your session is about to expire
← Back to Search
Ultrasound Group for Long COVID Syndrome (LOCUS Trial)
LOCUS Trial Summary
This trial aims to test the safety and effectiveness of using ultrasound stimulation on the spleen as a treatment for Long COVID. The study will measure the activity of the disease before, during, and after
LOCUS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowLOCUS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.LOCUS Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any available openings for patients to participate in this medical study?
"As per the information available on clinicaltrials.gov, this specific clinical trial is not currently accepting new participants. The initial posting of the study was on January 3rd, 2024, with the most recent update occurring on December 31st, 2023. However, it should be noted that there are presently 128 other ongoing clinical trials actively recruiting patients at this time."
What are the specific criteria for eligibility to participate in this medical study?
"To be eligible for enrollment in this clinical trial, individuals must have a diagnosis of long covid syndrome and fall between the ages of 18 and 65. The trial aims to recruit a total of 15 participants."
Does this research trial accept individuals aged 50 years and above as study participants?
"Prospective participants for this research are required to be of legal age and younger than 65 years old."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger